Funding · Seed · 16 September 2026
Axo Longevity raises £3.8m led by MS&AD Ventures
London-based Axo Longevity has raised £3.8m in a seed round, led by MS&AD Ventures. It builds a preventive health membership built on blood testing and personal action plans. Izou Partners, LifeX Ventures, Everywhere Ventures and others also invested. The money will go on more lab partners, an AI health copilot and new European markets.
65thRound size percentile, 20 seed rounds
Press report
CompanyAxo Longevity
StageSeed
SectorHealthTech
Based inLondon
InvestorsMS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital
SourcePress · confidence highView source ↗
Your note on Axo Longevity
Sign in to keep private notes on this company.
Is this your company?
Hide the valuation estimate straight away, add your investors, or tell us something's wrong. We check every change.